Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$402,263,651
+$82,494,412 QoQ
Shares Held
1,598,568
+8.7% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#97
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. ABBV ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
726,199 | $871,024,939 | |
| 2 | JNJ |
Johnson & Johnson
|
2,566,595 | $651,838,132 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,598,568 | $402,263,651 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,030,023 | $260,857,955 | |
| 5 | AMGN |
Amgen Inc
|
471,833 | $170,860,165 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,071,977 | $135,433,574 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,716,000 | $98,875,920 | |
| 8 | PFE |
Pfizer Inc
|
3,801,302 | $91,535,352 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $402,263,651 | 1,598,568 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $319,769,239 | 1,470,271 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $344,726,290 | 1,508,715 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $427,143,139 | 1,844,792 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $300,489,266 | 1,618,841 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $376,870,538 | 1,798,733 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $307,308,160 | 1,729,365 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $327,378,986 | 1,657,783 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $243,606,425 | 1,420,280 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $438,341,104 | 2,407,145 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $368,710,977 | 2,379,241 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $300,328,622 | 2,014,817 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $204,228,988 | 1,515,839 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $167,301,844 | 1,049,770 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $192,481,227 | 1,191,023 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $235,491,039 | 1,754,646 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $247,226,430 | 1,614,171 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $360,057,819 | 2,221,071 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $268,616,133 | 1,983,871 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $156,429,945 | 1,450,171 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $240,555,223 | 2,135,611 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $236,115,586 | 2,181,811 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $253,796,668 | 2,368,611 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $238,044,306 | 2,717,711 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $198,550,493 | 2,022,311 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||